Cooperative Agreement NU01DD000024

Award Date 9/30/23
Completion Date 9/29/27
Dollars Obligated $2M
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.184
Assistance Type
Cooperative Agreement
Place of Performance
Nevada, USA
Similar Awards
This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $149,000 in funding to the University of Oregon to conduct a longitudinal study examining the developmental trajectories of autonomic reactivity and regulation in children exposed prenatally to cannabis and tobacco. The key objectives of the study are to: 1) examine changes in parasympathetic nervous system functioning from infancy to early...
This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,499,606 to Dartmouth-Hitchcock Clinic to conduct a population-level analysis of 1.7 million maternal-infant dyads insured by Medicaid. The primary objectives are to: 1) characterize disparities in the diagnosis of neonatal opioid withdrawal syndrome (NOWS) across 150 hospitals; 2) determine the cumulative incidence of...
This National Institute on Drug Abuse (NIDA) Project Grant award under CFDA 93.279 (Drug Use and Addiction Research Programs) provides $390,635 to the University of Pittsburgh to develop a novel intervention that addresses prenatal depressive symptoms to encourage tobacco and cannabis cessation among marginalized pregnant and postpartum people. The key products and services to be delivered through this grant include: 1) Conducting formative research on the experiences of marginalized pregnant...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $196,236 to The Washington University to conduct research focused on disparities in the prescription and effectiveness of medications to treat opioid use disorder (OUD) during pregnancy. The key objectives of the 5-year project are to: 1) evaluate how race and racial segregation are associated with the use of buprenorphine and methadone as well...
The National Institutes of Health (NIH) awarded Boston Medical Center Corporation a $2,573,346 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The 3-year grant, which commenced on September 1, 2023, will fund a prospective cohort study comparing 100 opioid-exposed pregnancies to 50 non-exposed controls. The study aims to: Compare serial microRNA (miRNA) signatures in opioid-exposed and control pregnancies using maternal plasma and placental tissue samples. The...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $1,873,868 to Washington University to design and conduct a randomized controlled trial to assess the efficacy of contingency management (CM) in improving substance use disorder (SUD) treatment retention among pregnant patients. The study aims to develop and pilot protocols to address social needs and deliver CM to pregnant patients with SUD, then evaluate the...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, provides $187,143 to the University of California, San Diego to conduct a pilot study on patterns of alcohol and cannabis use before, during, and after pregnancy for both pregnant individuals and their partners. The key objectives are to: 1) characterize maternal and paternal patterns of alcohol and cannabis use over the course...
The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...

ESTABLISHING PUBLIC HEALTH DATA SYSTEMS TO TRACK PREGNANCY OUTCOMES AND CONDUCT LONGITUDINAL FOLLOW-UP FOR INDIVIDUALS WITH POLYSUBSTANCE ABUSE

Posted 8/31/23, 12:00 AM